Stock Events

Revium Recovery 

$1.5
8
+$0+0% Tuesday 20:00

Statistics

Day High
1.5
Day Low
1.5
52W High
1.5
52W Low
1.5
Volume
244
Avg. Volume
0
Mkt Cap
52.14M
P/E Ratio
0
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RVRC. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie manufactures and markets Humira, which is used in the treatment of autoimmune diseases, competing with Revium's therapies.
AMGEN
AMGN
Mkt Cap177.72B
Amgen produces Enbrel, a direct competitor to some of Revium Recovery's autoimmune treatment options.
Pfizer
PFE
Mkt Cap169.83B
Pfizer offers various drugs that compete in the autoimmune and inflammation markets, overlapping with Revium Recovery's product lines.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson, through its pharmaceutical division Janssen, provides several drugs that compete in the same therapeutic areas as Revium Recovery.
Biogen
BIIB
Mkt Cap32.96B
Biogen focuses on innovative therapies for neurological and neurodegenerative diseases, competing with Revium's neurological disorder treatments.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences offers treatments for HIV/AIDS, liver diseases, and other conditions, competing with Revium Recovery in the specialty treatment market.
Novartis
NVS
Mkt Cap232.42B
Novartis provides a wide range of healthcare solutions, including treatments for autoimmune diseases, directly competing with Revium Recovery.
Merck &
MRK
Mkt Cap318.55B
Merck produces drugs that target various diseases, including those in Revium Recovery's therapeutic areas, making them a competitor.
Roche
RHHBY
Mkt Cap220.72B
Roche, with its diverse portfolio, including treatments for cancer and autoimmune diseases, competes with Revium Recovery's offerings.
Sanofi
SNY
Mkt Cap128.21B
Sanofi focuses on areas such as immunology and inflammation, directly competing with Revium Recovery in the development of treatments for similar conditions.

About

Revium Recovery Inc. manufactures and markets alcoholic and non-alcoholic beverages in the United States. It offers structured and flavored waters, sports and energy drinks, green tea, and spirits. The company has a strategic alliance with Quantum TecH20. The company was formerly known as OC Beverages, Inc. and changed its name to Revium Recovery Inc. in December 2020. Revium Recovery Inc. is based in Irvine, California.
Show more...
CEO
Employees
3
Country
US
ISIN
US76151C1009

Listings

OTCM
US
RVRC